PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

phytonadione

Verify with FDA → · CMS NADAC pricing →

Brand names: Vitamin K1, Mephyton

Vitamin K Supplement Rx

Phytonadione is a vitamin K supplement. It helps your blood clot properly.

Drug Pricing (NADAC)

Generic Price

$12.59/unit

Generic Available

Yes (15 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

What it does

This medicine treats bleeding problems caused by low vitamin K levels.

Common side effects

No common side effects listed.

Key warnings

This medicine can cause severe reactions, including death, if given intravenously (into a vein) or intramuscularly (into a muscle).

How It Works

Phytonadione provides vitamin K1, which is needed to make certain clotting factors in your blood. These clotting factors help stop bleeding. By increasing these factors, phytonadione helps your blood clot normally.

How to Take It

Phytonadione is usually given as an injection by a healthcare provider. It can be injected under the skin, into a muscle, or into a vein. The dose depends on your condition and how you respond to the medicine. If injected into a vein, it should be given very slowly.

Pregnancy & Breastfeeding

It is not known if phytonadione can harm an unborn baby. Talk to your doctor if you are pregnant or breastfeeding.

Missed Dose

Since phytonadione is usually given by a healthcare provider, you are not likely to miss a dose. If you are giving yourself the injections, call your doctor if you miss a dose.

Storage

Store at room temperature (68 to 77°F) and protect from light. Keep the ampules in the carton until you are ready to use them.

Side Effects (from patient reports)

Based on 5,026 FDA adverse event reports.

Using the medicine for something it's not approved for
654
Feeling sick to your stomach
630
Throwing up
533
Feeling very tired
523
Difficulty breathing
486
The medicine is not working
485
Blood infection
446
Loose stools
436
Stomach pain
428
Difficulty passing stools
405

FDA Adverse Event Report Analysis

Detailed analysis of 8,078 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 1999–2025.

Total Reports

8,078

Death-Related Reports

1,508

Hospitalization Reports

3,758

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 4,012 (53%)
Male 3,520 (47%)

Age Distribution

0–17 932
18–44 992
45–64 1,708
65–74 1,205
75+ 1,185

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 OFF LABEL USE 654
2 NAUSEA 630
3 VOMITING 533
4 FATIGUE 523
5 DYSPNOEA 486
6 DRUG INEFFECTIVE 485
7 SEPSIS 446
8 DIARRHOEA 436
9 ABDOMINAL PAIN 428
10 CONSTIPATION 405
11 HEADACHE 372
12 ABDOMINAL DISTENSION 368
13 CONDITION AGGRAVATED 364
14 PYREXIA 346
15 ANAEMIA 344

Reactions in Death Reports

SEPSIS 344
MULTIPLE ORGAN DYSFUNCTION SYNDROME 304
OFF LABEL USE 297
DEATH 279
GENERAL PHYSICAL HEALTH DETERIORATION 279
VOMITING 278
ASCITES 274
NAUSEA 269
ABDOMINAL DISTENSION 265
ABDOMINAL PAIN 265

Reactions in Hospitalization Reports

OFF LABEL USE 350
DYSPNOEA 323
VOMITING 315
NAUSEA 311
SEPSIS 284
ANAEMIA 281
PNEUMONIA 259
DRUG INEFFECTIVE 258
PYREXIA 250
ABDOMINAL PAIN 246

Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

This medicine can cause severe reactions, including death, if given intravenously (into a vein) or intramuscularly (into a muscle). These reactions can resemble an allergic reaction, with shock and cardiac or respiratory arrest. Intravenous and intramuscular routes should only be used if subcutaneous injection is not possible.

Known Drug Interactions

minor heparin

If relatively large doses have been employed, it may be necessary when reinstituting anticoagulant therapy to use somewhat larger doses of the prothrombin-depressing anticoagulant, or to use one which acts on a different principle, such as heparin sodium.

Mechanism: Vitamin K helps blood clot, but heparin works to thin the blood using a different process that Vitamin K does not block.

What to do: Your doctor may use heparin if you need to thin your blood after taking Vitamin K.

Common Questions

What is phytonadione used for?
It is used to treat bleeding problems caused by low vitamin K levels.
How is phytonadione given?
It is given as an injection under the skin, into a muscle, or into a vein.
What should I do if I experience side effects?
Tell your doctor right away if you have any side effects.
Can I take phytonadione if I am pregnant?
Talk to your doctor if you are pregnant or breastfeeding.
How quickly does phytonadione work?
It should start working within a few hours to help your blood clot.
Will I need blood tests while taking this medicine?
Yes, your doctor will likely monitor your blood clotting times.
Can phytonadione interact with other medicines?
Yes, it can interact with blood thinners. Tell your doctor about all medicines you take.
What if the injection site is painful?
Pain, swelling, and tenderness can occur at the injection site.
Is phytonadione the same as vitamin K?
Yes, phytonadione is a form of vitamin K.
What should I avoid while taking phytonadione?
Follow your doctor's instructions about diet and other medications.
Does phytonadione interact with other medications?
Yes, phytonadione has 1 known drug interactions. Notable interactions include heparin. Always inform your doctor about all medications you are taking.
What drug class is phytonadione?
phytonadione belongs to the Vitamin K Supplement drug class. It requires a prescription (Rx). This medicine treats bleeding problems caused by low vitamin K levels.
Is phytonadione safe during pregnancy?
It is not known if phytonadione can harm an unborn baby. Talk to your doctor if you are pregnant or breastfeeding. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.

Related Medications in Vitamin K Supplement

Other drugs grouped near phytonadione — same-class peers and common alternatives.

Compare phytonadione vs ascorbic acid side-by-side →

Medication Guides

Related Health & Safety Data

Save on phytonadione

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for phytonadione

The FDA label for phytonadione (sold under brand names such as Vitamin K1, Mephyton) classifies it as a prescription-only medication in the Vitamin K Supplement class. This medicine treats bleeding problems caused by low vitamin K levels. Labeling covers dosing, contraindications, and monitoring requirements derived from clinical trials.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 5,026 voluntary reports. The database also lists 1 documented drug interaction derived from FDA labeling, with the top-flagged interaction rated minor severity. NADAC pricing from CMS shows a generic unit cost of $12.59.

Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.

Last updated: May 30, 2019

All federal data sources used on this page